Kaizen, Kai-who? – why ‘lean’ matters for pharma IT
Posted 1st March 2012 in Articles, General | Register to comment
Nick Plank talks about the move towards ‘lean’ management and Kaizen principles within pharma and how centralisation of IT supports these disciplines.
Lean management, six sigma, Kaizen philosophy applied to business – these terms have become familiar to those of us working …
Read the full articleEditor’s voice: February – top pharma innovators please!
Posted 29th February 2012 in Articles, General | Register to comment
Rebecca Aris shares the latest pharmaphorum news including an exciting opportunity to nominate your top innovator in pharma.
Before we review the highlights of our February content and look at what’s to come, we have some exciting news to share…
Read the full articleDevice ad-vice: Best practices for handling a medical device recall
Posted 28th February 2012 in Articles, Devices & Diagnostics, General | Register to comment
In part 2 of the “Device ad-vice” series, Amy Smith offers advice for best practices on dealing with medical device recalls.
Product recalls are a major headache for pharma, but device manufacturers can feel the pain, too. In the U.S., the FDA’s 510(k) process for…
Read the full articleSpotlight on… pancreatic cancer – the not-so silent killer
Posted 27th February 2012 in Articles, General | Register to comment
This month’s ‘spotlight on…’ article shines a light on the unmet medical needs of pancreatic cancer – the not-so silent killer.
Pancreatic cancer has long held the title of the “silent killer” as it is widely thought that patients do not develop symptoms until it…
Read the full articlePrejudice and Pride
Posted 24th February 2012 in Articles, General | 1 comment
In an animated story, Nick Broughton highlights the prevalence of prejudice towards pharma and discusses how it’s time we started to acknowledge it.
It was about 2am and I was tacking up Oxford Street in the peculiar manner universally adopted by those who have had one over…
Read the full articleGetting to the heart of the non-adherence epidemic
Posted 23rd February 2012 in Articles, General | 2 comments
Kate Reid addresses reasons for non-adherence and approaches to tackling this epidemic.
In these austere times when the NHS is charged with delivering efficiency challenges of £120 bn, tackling non-adherence to…
Read the full articleThe pharma summit 2012 – finding new directions
Posted 22nd February 2012 in Articles, Conferences, General | Register to comment
Rebecca Aris gives an overview of the topics discussed at the recent Economist conference ‘The pharma summit 2012 – finding new directions’.
R&D costs are increasing facing pharma with, according to the media, a ‘perfect storm’ resulting in a need to find a new direction for…
Read the full articleGreen pharmaceutical manufacturing
Posted 21st February 2012 in Articles, General, Interviews | Register to comment
Johan Geerinck shares with us the steps that Johnson & Johnson are taking towards sustainable processing and how the industry as a whole can become greener.
The demand for implementation of sustainable processing in the pharma industry is increasing and is becoming a…
Read the full articleMedical journal selection: pharma’s real estate search
Posted 20th February 2012 in Articles, General | 2 comments
Ryan McGuire explores the medical journal selection process in order to aid manuscripts in reaching their target audience.
Evaluating the medical journal landscape is the first step toward making sure manuscripts find their way to the appropriate home. In fact…
Read the full articleThe Indian pharmaceutical industry: a time of growth and change (part 2)
Posted 17th February 2012 in Articles, General, Interviews | Register to comment
In the second part of his two-part interview Tapan Ray offers insights into the adoption of social media by Indian pharma.
Concluding his thoughts on Indian pharma, Tapan Ray shares his views on social media adoption by the industry and what he thinks the future of…
Read the full article